Astoriom has announced that it has expanded the stability storage capabilities at its Tramore site in Ireland to meet demand for scalable, flexible, regulatory-compliant storage solutions from -60°C to -196°C and ICH (International Council for Harmonisation) temperature-controlled stability conditions.
Astoriom
The additional capacity will help to ensure greater storage availability, and continuous access to a full suite of controlled environmental conditions to support time-sensitive R&D and regulatory studies.
Astoriom launched its expanded dedicated cryogenic storage suite in Tramore last year. This investment complements the acquisitions of Nottingham-based MTS Cryo Stores and Cool Repair Scientific UK, and Flagship Biosciences’ North Carolina biorepository operations. These additional storage capabilities demonstrate the company’s dedication to expanding its future-ready and integrated global solutions for stability storage and biorepository services.
The Tramore facility complies with the highest industry standards, including ISO 9001 certifications, ensuring adherence to global regulatory requirements. It currently provides stability storage at precise temperature ranges for the safe preservation of samples for biopharmaceutical companies, biotechs, CROs/CDMOs, research institutions, medical device providers, and biobanks. This expansion enhances Astoriom's leadership in stability storage, biorepository services, disaster recovery, and validation.
Lori A. Ball, CEO, Astoriom, said: “With over 30 years’ experience, Astoriom has established itself as a trusted partner for safeguarding samples globally, operating state-of-the-art facilities in the US, UK, and Ireland. This expansion strengthens our global footprint and continues to serve the evolving needs of our R&D customers who are seeking high-quality, scalable, and regulatory-ready environments.”